Free Newsletter
Geron: Stem cells repair heart attack damage
Researchers from Geron and the University of Washington have completed new animal studies that offer fresh evidence of the ability of embryonic stem cells to repair the damage done by a heart attack. The team injected cardiac cells taken from human ESCs and injected them into rats four days after a heart attack. Not only did the stem cells rebuild damaged heart muscles, they also improved the function of the entire heart.
In a noted achievement, the researchers turned human ESCs into cardiac cells, or cardiomyocytes. This has been one of the toughest feats involved in stem cell research, and the investigators devised a culture technique that was effective in coaxing human ESCs to transform into cardiomyocytes with 90 percent accuracy. Pigs and sheep are next in line for testing with human trials about two years away.
- check out the release
- and read the report on the study from the Financial Times
Related Articles:
New study to use stem cells after heart attacks. Report
Geron reports breakthrough in stem cell research. Report
Stem cell companies target heart disease. Report
Heart muscle created from embryonic stem cells. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




